4.8 Article

Inhibition of autophagy and tumor growth in colon cancer by miR-502

期刊

ONCOGENE
卷 32, 期 12, 页码 1570-1579

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2012.167

关键词

miR-502; autophagy; p53; colon cancer

资金

  1. Stony Brook University Translational Research Laboratory [R01CA155019, R33CA147966]

向作者/读者索取更多资源

Autophagy is a catabolic process that allows cellular macromolecules to be broken down and recycled as metabolic precursors. The influence of non-coding microRNAs in autophagy has not been explored in colon cancer. In this study, we discover a novel mechanism of autophagy regulated by hsa-miR-502-5p (miR-502) by suppression of Rab1B, a critical mediator of autophagy. A number of other miR-502 suppressed mRNA targets (for example, dihydroorotate dehydrogenase) are also identified by microarray analysis. Ectopic expression of miR-502 inhibited autophagy, colon cancer cell growth and cell-cycle progression of colon cancer cells in vitro. miR-502 also inhibited in-vivo colon cancer growth in a mouse tumor xenografts model. In addition, the expression of miR-502 was regulated by p53 via a negative feedback regulatory mechanism. The expression of miR-502 was downregulated in colon cancer patient specimens compared with the paired normal control samples. These results suggest that miR-502 may function as a potential tumor suppressor and therefore be a novel candidate for developing miR-502-based therapeutic strategies. Oncogene (2013) 32, 1570-1579; doi:10.1038/onc.2012.167; published online 14 May 2012

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Lysosomal Targeting with Stable and Sensitive Fluorescent Probes (Superior LysoProbes): Applications for Lysosome Labeling and Tracking during Apoptosis

Xin Chen, Yue Bi, Tianyang Wang, Pengfei Li, Xin Yan, Shanshan Hou, Catherine E. Bammert, Jingfang Ju, K. Michael Gibson, William J. Pavan, Lanrong Bi

SCIENTIFIC REPORTS (2015)

Article Multidisciplinary Sciences

Highly Stable and Sensitive Fluorescent Probes (LysoProbes) for Lysosomal Labeling and Tracking

Nazmiye B. Yapici, Yue Bi, Pengfei Li, Xin Chen, Xin Yan, Srinivas Rao Mandalapu, Megan Faucett, Steffen Jockusch, Jingfang Ju, K. Michael Gibson, William J. Pavan, Lanrong Bi

SCIENTIFIC REPORTS (2015)

Article Oncology

miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression

Shixiang Guo, Xuejun Xu, Yichen Tang, Chaobin Zhang, Jian Li, Yongsheng Ouyang, Jingfang Ju, Ping Bie, Huaizhi Wang

CANCER LETTERS (2014)

Article Oncology

Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer

Peixin Dong, Masanori Kaneuchi, Ying Xiong, Liping Cao, Muyan Cai, Xishi Liu, Sun-Wei Guo, Jingfang Ju, Nan Jia, Yosuke Konno, Hidemichi Watari, Masayoshi Hosaka, Satoko Sudo, Noriaki Sakuragi

CARCINOGENESIS (2014)

Review Cell Biology

MicroRNA A third dimension in autophagy

Haiyan Zhai, Andrew Fesler, Jingfang Ju

CELL CYCLE (2013)

Article Oncology

Clinical Significance of Long Intergenic Noncoding RNA-p21 in Colorectal Cancer

Haiyan Zhai, Andrew Fesler, Kristina Schee, Oystein Fodstad, Kjersti Flatmark, Jingfang Ju

CLINICAL COLORECTAL CANCER (2013)

Editorial Material Chemistry, Medicinal

miRNA: the new frontier in cancer medicine

Jingfang Ju, Jingting Jiang, Andrew Fesler

FUTURE MEDICINAL CHEMISTRY (2013)

Article Genetics & Heredity

A frequent somatic mutation in CD274 3'-UTR leads to protein over-expression in gastric cancer by disrupting miR-570 binding

Weipeng Wang, Jing Sun, Fang Li, Rui Li, Yongping Gu, Cuiping Liu, Peng Yang, Ming Zhu, Lujun Chen, Wenyan Tian, Huan Zhou, Yong Mao, Liang Zhang, Jingting Jiang, Changping Wu, Dong Hua, Weichang Chen, Binfeng Lu, Jingfang Ju, Xueguang Zhang

HUMAN MUTATION (2012)

Article Gastroenterology & Hepatology

Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer

Ming Wang, Chenglong Li, Beiqin Yu, Liping Su, Jianfang Li, Jingfang Ju, Yingyan Yu, Qinlong Gu, Zhenggang Zhu, Bingya Liu

JOURNAL OF GASTROENTEROLOGY (2013)

Article Biochemistry & Molecular Biology

Genetic Variant rs16430 6bp>0bp at the microRNA-Binding Site in TYMS and Risk of Sporadic Breast Cancer Risk in Non-Hispanic White Women Aged ≤55 Years

Xiaoxiang Guan, Hongliang Liu, Jingfang Ju, Yangkai Li, Peng Li, Li-E Wang, Abenaa M. Brewster, Thomas A. Buchholz, Banu K. Arun, Qingyi Wei, Zhensheng Liu

MOLECULAR CARCINOGENESIS (2015)

Review Genetics & Heredity

Circulating microRNA Testing for the Early Diagnosis and Follow-up of Colorectal Cancer Patients

Andrew Fesler, Jingting Jiang, Haiyan Zhai, Jingfang Ju

MOLECULAR DIAGNOSIS & THERAPY (2014)

Article Biochemistry & Molecular Biology

Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis

P. Dong, M. Karaayvaz, N. Jia, M. Kaneuchi, J. Hamada, H. Watari, S. Sudo, J. Ju, N. Sakuragi

ONCOGENE (2013)

Review Biotechnology & Applied Microbiology

miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer

Andrew Fesler, Haiyan Zhai, Jingfang Ju

ONCOTARGETS AND THERAPY (2014)

Article Cell Biology

miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer

M. Karaayvaz, H. Zhai, J. Ju

CELL DEATH & DISEASE (2013)

暂无数据